Weuve et al. suggesting that exposure to DBP may be asso- ciated with increased risk of endometriosis and uterine leiomyomata, and that exposure to DEHP may be associated with reduced risk of these conditions. These findings warrant investigation in future prospective studies. Ref Rencs Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, et al. 2008. Characterization of phthalate expo- sure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect 116:467–473. Agarwal DK, Lawrence WH, Autian J. 1985. Antifertility and mutagenic effects in mice from parenteral administration of di-2-ethylhexyl phthalate (DEHP). J Toxicol Environ Health 16:71–84. Agarwal DK, Lawrence WH, Turner JE, Autian J. 1989. Effects of parenteral di-(2-ethylhexyl)phthalate (DEHP) on gonadal biochemistry, pathology, and reproductive performance of mice. J Toxicol Environ Health 26:39–59. Andersen J. 1998. Factors in fibroid growth. Baillieres Clin Obstet Gynaecol 12:225–243. Arcadi FA, Costa C, Imperatore C, Marchese A, Rapisarda A, Salemi M, et al. 1998. Oral toxicity of bis(2-ethylhexyl) phthalate during pregnancy and suckling in the Long- Evans rat. Food Chem Toxicol 36:963–970. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. 2000. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 85:2897–2902. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. 2003. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107. Baird DD, Saldana TM, Nepomnaschy PA, Hoppin JA, Longnecker MP, Weinberg CR, et al. 2009. Within-person variability in urinary phthalate metabolite concentra- tions: measurements from specimens after long-term fro- zen storage. J Expo Sci Environ Epidemiol; doi:10.1038/ jes.2009.17 [Online 11 March 2009]. Berman E, Laskey JW. 1993. Altered steroidogenesis in whole- ovary and adrenal culture in cycling rats. Reprod Toxicol 7:349–358. Blount BC, Milgram KE, Silva MJ, Malek NA, Reidy JA, Needham LL, et al. 2000a. Quantitative detection of eight phthalate metabolites in human urine using HPLC- APCI-MS/MS. Anal Chem 72:4127–4134. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, et al. 2000b. Levels of seven urinary phtha- late metabolites in a human reference population. Environ Health Perspect 108:979–982. Breslow NE, Day NE. 1987. Statistical methods in cancer research. Vol 2. The design and analysis of cohort studies. IARC Sci Publ 82:1–406. CDC (Centers for Disease Control and Prevention). 2005. Anallytic and Reporting Guidelines: The National Health and Nutrition Examination Survey. Available: http://www.cdc.gov/nchs/ data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_ dec_2005.pdf [accessed 4 August 2008]. CDC (Centers for Disease Control and Prevention). 2009. National Health and Nutrition Examination Survey. Hyattsville, MD:U.S. Department of Health and Human Services, National Center for Health Statistics. Available: http://www. cdc.gov/nchs/nhanes.htm [accessed 13 July 2009]. Cobellis L, Latini G, Felice CD, Razzi S, Paris I, Ruggieri F, et al. 2003. High plasma concentrations of di-(2-ethylhexyl)- phthalate in women with endometriosis. Hum Reprod 18:1512–1515. Davis BJ, Maronpot RR, Heindel JJ. 1994a. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol 128:216–223. Davis BJ, Weaver R, Gaines LJ, Heindel JJ. 1994b. Mono-(2- ethylhexyl) phthalate suppresses estradiol production independent of FSH-cAMP stimulation in rat granulosa cells. Toxicol Appl Pharmacol 128:224–228. Dizerega GS, Barber DL, Hodgen GD. 1980. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppres- sion. Fertil Steril 33:649–653. Ema M, Miyawaki E, Kawashima K. 1998. Reproductive effects 832 of butyl benzyl phthalate in pregnant and pseudopregnant rats. Reprod Toxicol 12:127–132. Malspeis S, Willett WC, et al. 2004a. Reproductive history and endometriosis among premenopausal women. Obstet Ema M, Miyawaki E, Kawashima K. 2000. Effects of dibutyl Gynecol 104:965–974. phthalate on reproductive function in pregnant and Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, pseudopregnant rats. Reprod Toxicol 14:13–19. Obstet Gynecol Clin North Am 24:235–258. Eskenazi B, Warner ML. 1997. Epidemiology of endometriosis. Marshall LM, Hunter DJ. 2004b. Incidence of laparoscopi- cally confirmed endometriosis by demographic, anthropo- metric, and lifestyle factors. Am J Epidemiol 160:784–796. Farquhar CM, Steiner CA. 2002. Hysterectomy rates in the Missmer SA, Mohllajee AP. 2008. The etiology of endometrio- United States 1990–1997. Obstet Gynecol 99:229–234. Flynn M, Jamison M, Datta S, Myers E. 2006. Health care sis: environment. In: Endometriosis 2008 (Rombauts L, Tsaltas J, Maher P, Healy D, eds). Oxford:Blackwell. resource use for uterine fibroid tumors in the United Picard K, Lhuguenot J-C, Lavier-Canivenc M-C, Chagnon M-C. States. Am J Obstet Gynecol 195:955–964. Friedman AJ, Lobel SM, Rein MS, Barbieri RL. 1990. Efficacy and safety considerations in women with uterine leio- myomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Am J Obstet Gynecol 163:1114–1119. Gurates B, Bulun SE. 2003. Endometriosis: the ultimate hor- monal disease. Semin Reprod Med 21:125–134. Harris CA, Henttu P, Parker MG, Sumpter JP. 1997. The estro- genic activity of phthalate esters in vitro. Environ Health Perspect 105:802–811. Occup Environ Med 62:806–818. 72:510–514. BJOG 113:515–520. 108:791–793. 2001. Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule(s). Toxicol Appl Pharmacol 172:108–118. Potgieter HC, Magagane F, Bester MJ. 1995. Oestrogen and progesterone receptor status and PgR/ER ratios in nor- mal and myomatous human myometrium. East Afr Med J Reddy BS, Rozati R, Reddy BVR, Raman N. 2006. Association of phthalate esters with endometriosis in Indian women. Rein MS. 2000. Advances in uterine leiomyoma research: Hauser R, Calafat AM. 2005. Phthalates and human health. the progesterone hypothesis. Environ Health Perspect Hauser R, Duty S, Godfrey-Bailey L, Calafat AM. 2004. Rein MS, Barbieri RL, Friedman AJ. 1995. Progesterone: a Medications as a source of human exposure to phthalates. critical role in the pathogenesis of uterine myomas. Am J Environ Health Perspect 112:751–753. Obstet Gynecol 172:14–18. Hernán MA, Hernández-Díaz S, Robins JM. 2004. A structural Rein MS, Nowak RA. 1992. Biology of uterine myomas and myo- approach to selection bias. Epidemiology 15:615–625. metrium in vitro. Semin Reprod Endocrinol 10:310–319. Hernández-Díaz S, Mitchell AA, Kelley KE, Calafat AM, Schwartz SM. 2001. Epidemiology of uterine leiomyomata. Clin Hauser R. 2009. Medications as a potential source of expo- sure to phthalates in the U.S. population. Environ Health Perspect 117:185–189. Obstet Gynecol 44:316–326. Schwartz SM, Marshall LM. 2000. Uterine leiomyomata. In: Women Health (Goldman MB, Hatch MC, eds). San Hoppin JA, Brock JW, Davis BJ, Baird DD. 2002. Reproducibility Diego:Academic Press, 240–252. of urinary phthalate metabolites in first morning urine Schwartz SM, Marshall LM, Baird DD. 2000. Epidemiologic samples. Environ Health Perspect 110:515–518. Hornung RW, Reed L. 1990. Estimation of average concentra- contributions to understanding the etiology of uterine leio- myomata. Environ Health Perspect 108:821–827. tion in the presence of nondetectable values. Appl Occup Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Itoh H, Iwasaki M, Hanaoka T, Sasaki H, Tanaka T, Tsugane S. Silva MJ, Malek NA, Hodge CC, Reidy JA, Kato K, Barr DB, Environ Hyg 5:46–51. 6:167–191. Houston DE. 1984. Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol Rev 2009. Urinary phthalate monoesters and endometriosis in infertile Japanese women. Sci Total Environ 408:37–42. Jackson S. 1966. Creatinine in urine as an index of urinary excretion rate. Health Phys 12:843–850. Jung BH, Bai SW, Chung BC. 2004. Endogenous urinary ste- roids in premenopausal women with uterine leiomyomas. Int J Gynecol Obstet 84:55–60. Kato K, Silva MJ, Brock JW, Reidy JA, Malek NA, Hodge CC, et al. 2003. Quantitative detection of nine phthalate metabolites in human serum using reversed-phase high-performance liquid chromatography-electrospray ionization-tandem mass spec- trometry. J Anal Toxicol 27:284–289. et al. 2004. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phtha- late. Environ Health Perspect 112:327–330. Lamb JC, Chapin RE, Teague J, Lawton AD, Reel JR. 1987. Reproductive effects of four phthalic acid esters in the mouse. Toxicol Appl Pharmacol 88:255–269. et al. 2004. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999–2000. Environ Health Perspect 112:331–338. et al. 2003. Improved quantitative detection of 11 urinary phthalate metabolites in humans using liquid chroma- tography-atmospheric pressure chemical ionization tan- dem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 789:393–404. Simoens S, Hummelshoj L, D’Hooghe T. 2007. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 13:395–404. Strauss J, Coutifaris C. 1999. The endometrium and myometrium: regulation and dysfunction. In: Reproductive Endocrinology (Yen S, Jaffe JM, Barbieri RL, eds). Philadelphia:W.B. Saunders, 218–256. Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 6th ed. (Strauss JF, Barbieri RL, eds). Philadelphia:Saunders Elsevier, 577–596. U.S. Food and Drug Administration. 2002. Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices. Rockville, MD:U.S. Food and Drug Administration, Center for Devices and Radiological Health. Kato K, Silva MJ, Reidy JA, Hurtz D III, Malek NA, Needham LL, Taylor RN, Lebovic DI. 2009. Endometriosis. In: Yen & Jaffe’s Laskey JW, Berman E. 1993. Steroidogenic assessment using Velebil P, Wingo PA, Xia Z, Wilcox LS, Peterson HB. 1995. ovary culture in cycling rats: effects of bis(2-diethylhexyl) phthalate on ovarian steroid production. Reprod Toxicol 7:25–33. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol 86:764–769. Lovekamp TN, Davis BJ. 2001. Mono-(2-ethylhexyl) phthalate Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells. Toxicol Appl Pharmacol 172:217–224. Luisi S, Latini G, de Felice C, Sanseverino F, di Pasquale D, Mazzeo P, et al. 2006. Low serum concentrations of di-(2- ethylhexyl)phthalate in women with uterine fibromatosis. Gynecol Endocrinol 22:92–95. HB. 1994. Hysterectomy in the United States, 1988–1990. Obstet Gynecol 83:549–555. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, et al. 2004. Reproductive factors, hormonal contraception and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 159:113–123. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Wise LA, Palmer JR, Stewart EA, Rosenberg L. 2005. Age- Manson JE, Colditz GA, et al. 1997. Variation in the inci- dence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90:967–973. specific incidence rates for self-reported uterine leiomyo- mata in the Black Women’s Health Study. Obstet Gynecol 105:563–568. Missmer SA, Cramer DW. 2003. The epidemiology of endo- Zondervan KT, Cardon LR, Kennedy SH. 2002. What makes a metriosis. Obstet Gynecol Clin North Am 30:1–19. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 17:1415–1423. ovlume 118 | number 6 | June 2010 • Environmental Health Perspectives